The observed increase in radiosensitivity upon BCL-3 depletion suggests that rectal patients who have higher tumour BCL-3 expression would be less likely to respond to neo-adjuvant radiotherapy, therefore stratification of therapy by BCL-3 expression could avoid unnecessary treatment or necessitate the addition of adjunctive therapies to improve therapeutic response [53]. Here, BCL3 is linked to neoplasm.